← Back
$AGIO All transactions

AGIOS PHARMACEUTICALS, INC.

M

$ Value

$0

Shares

1,977

Price

$0

Filed

Jun 17

Insider

Name

Owen Adams Catherine

Title

CIK

0001816838

Roles

Director

Transaction Details

Transaction Date

2025-06-13

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

3,953

Footnotes

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. | The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Filing Info

Accession No.

0001439222-25-000043

Form Type

4

Issuer CIK

0001439222

Owen Adams Catherine's History

Date Ticker Type Value
2026-03-25 ACAD $250K
2026-03-24 ACAD M $0
2026-03-24 ACAD M $0
2025-06-20 AGIO M $0
2025-06-20 AGIO M $0
2025-06-18 AGIO A $0
2025-06-18 AGIO A $0
2025-06-13 AGIO M $0
2025-06-13 AGIO M $0

Other Insiders at AGIO (90d)

Insider Bought Sold Last
Goff Brian
Chief Executive Officer
$662K 2026-04-02
Jones Cecilia
Chief Financial Officer
$109K 2026-04-02
Gheuens Sarah
Chief Medical Officer
$102K 2026-04-02
Burns James William
Chief Legal Officer
$114K 2026-04-02
Milanova Tsveta
Chief Commercial Officer
$113K 2026-04-02
Viswanadhan Krishnan
Chief Corp Dev & Strategy
$103K 2026-04-02